These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 33731178)

  • 41. Impact of Public Health and Social Measures on the COVID-19 Pandemic in the United States and Other Countries: Descriptive Analysis.
    Zweig SA; Zapf AJ; Xu H; Li Q; Agarwal S; Labrique AB; Peters DH
    JMIR Public Health Surveill; 2021 Jun; 7(6):e27917. PubMed ID: 33975277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. COVID-19, Australia: Epidemiology Report 17 (Fortnightly reporting period ending 24 May 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32517645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England.
    de Lusignan S; Lopez Bernal J; Zambon M; Akinyemi O; Amirthalingam G; Andrews N; Borrow R; Byford R; Charlett A; Dabrera G; Ellis J; Elliot AJ; Feher M; Ferreira F; Krajenbrink E; Leach J; Linley E; Liyanage H; Okusi C; Ramsay M; Smith G; Sherlock J; Thomas N; Tripathy M; Williams J; Howsam G; Joy M; Hobbs R
    JMIR Public Health Surveill; 2020 Apr; 6(2):e18606. PubMed ID: 32240095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom.
    Rigoine de Fougerolles T; Puig-Barbera J; Kassianos G; Vanhems P; Schelling J; Crepey P; de Lejarazu RO; Ansaldi F; Fruhwein M; Galli C; Mosnier A; Pariani E; Rasuli A; Vitoux O; Watkins J; Weinke T; Bricout H
    Influenza Other Respir Viruses; 2022 May; 16(3):417-428. PubMed ID: 34866344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-International Travel-Related Measures.
    Ryu S; Gao H; Wong JY; Shiu EYC; Xiao J; Fong MW; Cowling BJ
    Emerg Infect Dis; 2020 May; 26(5):961-966. PubMed ID: 32027587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Developing pandemic preparedness in Europe in the 21st century: experience, evolution and next steps.
    Nicoll A; Brown C; Karcher F; Penttinen P; Hegermann-Lindencrone M; Villanueva S; Ciotti M; Jean-Gilles L; Rehmet S; Nguyen-Van-Tam JS
    Bull World Health Organ; 2012 Apr; 90(4):311-7. PubMed ID: 22511829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19, Australia: Epidemiology Report 19 (Fortnightly reporting period ending 21 June 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32600222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Travel time to health facilities in areas of outbreak potential: maps for guiding local preparedness and response.
    Hulland EN; Wiens KE; Shirude S; Morgan JD; Bertozzi-Villa A; Farag TH; Fullman N; Kraemer MUG; Miller-Petrie MK; Gupta V; Reiner RC; Rabinowitz P; Wasserheit JN; Bell BP; Hay SI; Weiss DJ; Pigott DM
    BMC Med; 2019 Dec; 17(1):232. PubMed ID: 31888667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19, Australia: Epidemiology Report 16 (Reporting week to 23:59 AEST 17 May 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 May; 44():. PubMed ID: 32522141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are we ready to deal with a global COVID-19 pandemic? Rethinking countries' capacity based on the Global Health Security Index.
    Ji Y; Shao J; Tao B; Song H; Li Z; Wang J
    Int J Infect Dis; 2021 May; 106():289-294. PubMed ID: 33823282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Community interventions in Low-And Middle-Income Countries to inform COVID-19 control implementation decisions in Kenya: A rapid systematic review.
    Abdullahi L; Onyango JJ; Mukiira C; Wamicwe J; Githiomi R; Kariuki D; Mugambi C; Wanjohi P; Githuka G; Nzioka C; Orwa J; Oronje R; Kariuki J; Mayieka L
    PLoS One; 2020; 15(12):e0242403. PubMed ID: 33290402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early assessment of the impact of mitigation measures on the COVID-19 outbreak in Italy.
    Vicentini C; Bordino V; Gardois P; Zotti CM
    Public Health; 2020 Aug; 185():99-101. PubMed ID: 32593056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serving the Vulnerable: The World Health Organization's Scaled Support to Countries During the First Year of the COVID-19 Pandemic.
    Pereira Bajard M; Stephens N; Eidman J; Warren KT; Molinaro P; McDonough-Thayer C; Rovaletti R; Acharya SP; Graaff PJ; Samaan G
    Front Public Health; 2022; 10():837504. PubMed ID: 35359755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Policy and Funding Decisions on COVID-19 Surveillance Operations and Case Reports - South Sudan, April 2020-February 2021.
    Shragai T; Summers A; Olushayo O; Rumunu J; Mize V; Laku R; Bunga S
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(22):811-817. PubMed ID: 34081689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID Border Accountability Project, a hand-coded global database of border closures introduced during 2020.
    Shiraef MA; Hirst C; Weiss MA; Naseer S; Lazar N; Beling E; Straight E; Feddern L; Taylor NR; Jackson C; Yu W; Bhaskaran A; Mattar L; Amme M; Shum M; Mitsdarffer ML; Sweere J; Brantley SE; Schenoni LL; Lewis-Beck C;
    Sci Data; 2021 Sep; 8(1):253. PubMed ID: 34588463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improvements in pandemic preparedness in 8 Central American countries, 2008-2012.
    Johnson LE; Clará W; Gambhir M; Chacón-Fuentes R; Marín-Correa C; Jara J; Minaya P; Rodríguez D; Blanco N; Iihoshi N; Orozco M; Lange C; Pérez SV; Amador N; Widdowson MA; Moen AC; Azziz-Baumgartner E
    BMC Health Serv Res; 2014 May; 14():209. PubMed ID: 24886275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study.
    Migliori GB; Thong PM; Alffenaar JW; Denholm J; Tadolini M; Alyaquobi F; Al-Abri S; Blanc FX; Buonsenso D; Chakaya J; Cho JG; Codecasa LR; Danila E; Duarte R; Dukpa R; García-García JM; Gualano G; Kurhasani X; Manika K; Mello FCQ; Pahl K; Rendon A; Sotgiu G; Souleymane MB; Thomas TA; Tiberi S; Kunst H; Udwadia ZF; Goletti D; Centis R; D'Ambrosio L; Silva DR
    J Bras Pneumol; 2022; 48(2):e20220087. PubMed ID: 35475873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of the Implementation of the International Health Regulations during the COVID-19 Pandemic: Portugal as a Case Study.
    Queiroz G; Maia J; Gomes F; Chen-Xu J; China J; Carmezim Pereira S; Pita Ferreira P; Ramalho J; Roque J; Teixeira JP; Carvalho C; Oliveira L; Simões D; Gomes J; Lopes C; Correia T
    Acta Med Port; 2023 Dec; 36(12):819-825. PubMed ID: 37819731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 in the least developed, fragile, and conflict-affected countries - How can the most vulnerable be protected?
    Ebrahim SH; Gozzer E; Ahmed Y; Imtiaz R; Ditekemena J; Rahman NMM; Schlagenhauf P; Alqahtani SA; Memish ZA
    Int J Infect Dis; 2021 Jan; 102():381-388. PubMed ID: 33130196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.